Benzinga's Top Upgrades (ACN, ORCL, AON, AMGN)

Accenture Plc ACN was upgraded by Jefferies from "hold" to "buy." ACN's shares closed at $46.67 yesterday. Accenture's trailing-twelve-month ROE is 62.80%. Oppenheimer upgrade Oracle Corporation ORCL from “perform” to “outperform.” ORCL's shares closed at $30.27 yesterday. ORCL reported 47% y/y surge in its FQ2 revenue. JP Morgan upgrade Aon Corporation AON from "neutral" to "overweight." AON's shares closed at $44.49 yesterday. AON's trailing-twelve-month revenue is $7.68 billion. Analysts at Leerink upgrade Amgen Inc AMGN from “market perform” to “outperform.” AMGN's shares closed at $56.63 yesterday. Amgen's trailing-twelve-month operating margin is 37.81%. More Analyst Ratings here
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: UpgradesMarketsAnalyst RatingsBiotechnologyHealth CareInformation TechnologyIT Consulting & Other ServicesSystems Softwaretop upgrades
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!